拓新药业
(301089)
| 流通市值：24.35亿 | | | 总市值：34.07亿 |
| 流通股本：9047.01万 | | | 总股本：1.27亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 115,672,906.05 | 140,264,360.55 | 69,555,511.74 | 67,363,765.33 |
| 交易性金融资产 | 115,556,263.01 | 105,147,519.18 | 185,276,136.12 | 215,755,247.22 |
| 应收票据及应收账款 | 68,277,360.25 | 79,178,227.6 | 94,941,544.96 | 83,559,121.23 |
| 其中：应收票据 | 22,815,761.56 | 20,588,112.5 | 16,716,279.79 | 12,504,378.19 |
| 应收账款 | 45,461,598.69 | 58,590,115.1 | 78,225,265.17 | 71,054,743.04 |
| 应收款项融资 | 51,314,997.38 | 46,942,361.45 | 37,497,057.8 | 50,096,831.08 |
| 预付款项 | 8,688,040.01 | 7,394,739.87 | 8,191,633.71 | 4,976,769.55 |
| 其他应收款合计 | 171,120 | 57,500 | 198,300.17 | 248,166.03 |
| 存货 | 196,292,549.25 | 181,611,833.75 | 190,791,788.13 | 189,254,997.27 |
| 一年内到期的非流动资产 | 11,158.09 | 11,051.38 | 10,945.69 | 10,841.01 |
| 其他流动资产 | 24,423,273.36 | 24,343,481.17 | 21,930,723.14 | 23,247,506.76 |
| 流动资产合计 | 580,407,667.4 | 584,951,074.95 | 608,393,641.46 | 634,513,245.48 |
| 非流动资产: | | | | |
| 长期应收款 | 273,567.29 | 270,950.85 | 268,359.43 | 265,792.8 |
| 其他权益工具投资 | 19,703,457.49 | 19,703,457.49 | 17,946,587.22 | 7,946,587.22 |
| 固定资产 | 802,010,182.69 | 814,549,811.09 | 816,687,624.08 | 831,950,470.25 |
| 在建工程 | 43,968,877.08 | 44,705,317.41 | 40,221,574.6 | 26,041,512.67 |
| 使用权资产 | 3,272,063.75 | 3,511,483.07 | 3,750,902.39 | 3,990,321.71 |
| 无形资产 | 79,418,682.66 | 80,119,768.49 | 79,733,268.72 | 80,430,950.42 |
| 长期待摊费用 | 3,375,700.24 | 3,617,354.77 | 2,872,103.65 | 3,568,012.96 |
| 递延所得税资产 | 74,077,688.09 | 70,978,697.06 | 75,468,010.95 | 72,496,877.68 |
| 其他非流动资产 | 44,462,548.08 | 42,888,489.77 | 44,023,089.22 | 46,026,208.97 |
| 非流动资产合计 | 1,070,562,767.37 | 1,080,345,330 | 1,080,971,520.26 | 1,072,716,734.68 |
| 资产总计 | 1,650,970,434.77 | 1,665,296,404.95 | 1,689,365,161.72 | 1,707,229,980.16 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 109,382,513.2 | 118,014,317.62 | 103,406,292.77 | 109,892,709.28 |
| 其中：应付票据 | 33,627,946.2 | 37,966,345.48 | 30,499,546.73 | 29,520,674.57 |
| 应付账款 | 75,754,567 | 80,047,972.14 | 72,906,746.04 | 80,372,034.71 |
| 合同负债 | 5,742,209.3 | 1,694,422.74 | 2,968,011.02 | 510,468.64 |
| 应付职工薪酬 | 8,690,305.11 | 10,193,465.29 | 8,288,550.03 | 8,449,552.7 |
| 应交税费 | 2,400,237.21 | 3,193,140.57 | 1,995,004.95 | 2,116,029.66 |
| 其他应付款合计 | 4,114,519.36 | 4,284,462.3 | 4,111,476.69 | 4,415,949.59 |
| 一年内到期的非流动负债 | 1,019,919.66 | 1,010,165.59 | 880,568.02 | 839,901.22 |
| 其他流动负债 | 9,970,273.59 | 7,579,453.26 | 8,193,373.99 | 7,373,963.18 |
| 流动负债合计 | 141,319,977.43 | 145,969,427.37 | 129,843,277.47 | 133,598,574.27 |
| 非流动负债: | | | | |
| 租赁负债 | 2,262,978.44 | 2,241,333.83 | 2,339,832.99 | 3,465,635.12 |
| 递延收益 | 30,103,526.49 | 30,545,583.08 | 31,400,206.04 | 32,254,829 |
| 递延所得税负债 | 2,385,765.5 | 2,363,375.22 | 3,422,861.69 | 3,671,430.88 |
| 非流动负债合计 | 34,752,270.43 | 35,150,292.13 | 37,162,900.72 | 39,391,895 |
| 负债合计 | 176,072,247.86 | 181,119,719.5 | 167,006,178.19 | 172,990,469.27 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 126,544,500 | 126,544,500 | 126,544,500 | 126,544,500 |
| 资本公积 | 621,109,964.85 | 621,109,964.85 | 621,109,964.85 | 621,109,964.85 |
| 其他综合收益 | 3,527,593.12 | 3,527,593.12 | 2,209,940.41 | 2,209,940.41 |
| 专项储备 | 1,231,162.53 | - | - | - |
| 盈余公积 | 65,222,535.36 | 65,222,535.36 | 65,222,535.36 | 65,222,535.36 |
| 未分配利润 | 657,262,431.05 | 667,772,092.12 | 707,272,042.91 | 719,152,570.27 |
| 归属于母公司股东权益合计 | 1,474,898,186.91 | 1,484,176,685.45 | 1,522,358,983.53 | 1,534,239,510.89 |
| 股东权益合计 | 1,474,898,186.91 | 1,484,176,685.45 | 1,522,358,983.53 | 1,534,239,510.89 |
| 负债和股东权益合计 | 1,650,970,434.77 | 1,665,296,404.95 | 1,689,365,161.72 | 1,707,229,980.16 |
| 公告日期 | 2026-04-28 | 2026-03-28 | 2025-10-29 | 2025-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |